- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02845310
The Effect of Intraoperative Goal Directed Restricted Fluid Therapy on Extravascular Lung Water
The Effect of Intraoperative Goal Directed Restricted Fluid Therapy Guided by Stroke Volume Variation Versus Standard Fluid Therapy on Extravascular Lung Water in Major Abdominal Operations: a Randomized Controlled Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Perioperative fluid management has an important impact on patient outcome. Under-resuscitation leads to hypoperfusion and over-resuscitation leads to tissue oedema. Intraoperative goal directed fluid therapy (GDT) has been reported to improve patient outcome in high risk surgical patients. GDT aims to optimize oxygen delivery through various strategies. The main three GDT strategies are:
- Stroke volume optimization with fluids
- Stroke volume variation (SVV) and pulse pressure variation (PPV) optimization with fluids.
- Oxygen delivery index with fluids and inotropes Although GDT was recommended by professional societies in Europe and United Kingdom, these recommendations were recently challenged in many randomized controlled trials and meta-analysis.The effect of GDT on intraoperative fluid requirements was previously reported, however; its effect on extravascular lung water is not well studied.
Electrical cardiometry is a recent non-invasive technology for cardiac output measurement. Electrical cardiometry drive CO measurement from thoracic electrical bioimpedance. Good correlation was reported between CO measurements derived from electrical cardiometry and continuous thermodilution monitoring system.
Although many protocols for GDT have been reported in major abdominal operations, till now there is no consensus about the optimum protocol nor the optimum goals to achieve during fluid management. Major abdominal operations are characterized by major fluid shifts. Moreover, patients undergoing these operations are prone to impaired organ functions due to tissue oedema. Traditional standard care in major abdominal operations usually includes 6 ml/Kg/h balanced crystalloids (to restore insensible losses and maintenance requirements) in addition to replacement of blood losses. We hypothesize that the use of a more restricted fluid approach (2ml/Kg/h) + GDT guided by cardiometry will improve fluid management and decrease extra-vascular lung water.
The aim of this study is to compare the use of Goal Directed fluid therapy guided by Stroke volume variation plus a restricted fluid management approach to standard fluid management in patients undergoing major abdominal operations.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt
- Cairo University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients scheduled for major abdominal operations
Exclusion Criteria:
- Patients with arrhythmias, pulmonary hypertension or impaired cardiac contractility.
- Patients with impaired liver or kidney function.
- Patients with BMI above 40.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Restricted fluid therapy group
Patients will receive restricted fluid management guided by concomitant SVV monitoring.
GDT protocol
|
Patients will receive restricted fluid management (2ml/Kg/h) with concomitant SVV monitoring using ICON cardiometry device.
GDT protocol will be used to fulfil the two targets (SVV < 10% - MAP >65 mmHg).
A fluid bolus of 200 ml Lactated ringer will be infused if SVV is more than 10% for 5 minutes, the dose will be repeated every 10 minutes if SVV is still above 10%.
If the total fluid boluses reached 20 ml/Kg in a patient with MAP > 65 mmHg, no fluid boluses will be infused unless there is evident blood loss or hypotension.
If MAP was achieved (>65mmHg) at any time, the first three steps in the protocol will be bypassed.
If MAP was not achieved after reaching 20 ml/Kg , norepinephrine (inotropes) will be given as shown in fig. 1 with dose of 0.01ug/kg/min.
|
|
Placebo Comparator: Control group
Patients will receive standard fluid management.
|
Patients will receive standard fluid management of 6 ml/Kg/h plus rescue fluid boluses of 200 ml lactated ringer if Mean arterial pressure (MAP) decreased less than 65 mmHg and central venous pressure less than 8 mmH2o.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Extravascular lung water (Lung ultrasound score)
Time Frame: Lung ultrasound will be performed in the postoperative care unit 30 minutes after patient recovery
|
Lung ultrasound with a 5-MHz curved array probe (MindrayDC-N6; Mindray; Shenzhen, China). Lung ultrasound will be assessed for the presence of B lines. The B line is the name given to an artifact with seven features: a hydroaeric comet-tail artifact; arising from the pleural line; hyperechoic; well defined; spreading up indefinitely; erasing A lines; and moving with lung sliding when lung sliding is present. The lung ultrasound score was obtained by scanning 12-rib interspaces with the probe longitudinally applied perpendicular to the wall. Each hemi-thorax was divided in six areas: two anterior areas, two lateral areas, and two posterior areas. The sum of B-lines found on each scanning site (0: absence; 1: B7 lines: multiple B-lines 7 mm apart; 2: B3 lines: multiple B 3 mm apart; 3: consolidation) yields a score from 0 to 36. |
Lung ultrasound will be performed in the postoperative care unit 30 minutes after patient recovery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intraoperative fluid requirement
Time Frame: intraoperatively
|
The total volume of fluids infused intraoperatively in milliliters
|
intraoperatively
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- N-16-2016
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surgery
-
MedtronicCompletedThoracic Surgery | Spine Surgery | Upper Extremity Surgery | Lower Extremity Surgery | Intracranial Surgery | Extracranial Surgery | Intratemporal Surgery | Extratemporal Surgery | Neck SurgeryGermany
-
[Redacted]3M; Solventum US LLCWithheldAbdominal Surgery | Orthopedic Surgery | Vascular Surgery | Cardiovascular SurgeryUnited States
-
Vanderbilt UniversityCompletedHand Surgery | Wrist Surgery | Forearm Surgery | Elbow SurgeryUnited States
-
Nantes University HospitalCompletedGynecological Surgery | Plastic Surgery | ENT SurgeryFrance
-
Baylor Research InstituteChiesi USA, Inc.CompletedSurgery | Cardiac Surgery | Surgery--Complications | Percutaneous Coronary InterventionUnited States
-
Maquet Cardiopulmonary GmbHNAMSATerminatedCardiac Surgery | Cardiopulmonary Bypass | Thoracic Surgery | Vascular SurgerySpain, Italy
-
Vanderbilt UniversityEdwards LifesciencesCompletedCardiac Surgery | Thoracic Surgery | Heart Surgery | Heart Transplant
-
Edwards LifesciencesCompletedAbdominal Surgery | Pelvic Surgery | Non-Cardiac/ Non-Thoracic Surgery | Major Peripheral Vascular SurgeryUnited States
-
Centre Hospitalier Universitaire de NīmesNot yet recruitingAnesthesia, Local | Foot Surgery | Hand Surgery | Walant SurgeryFrance
-
Eurosets S.r.l.RecruitingCardiac Surgery | Cardiopulmonary Bypass | Heart Surgery | Aortic Valve Surgery | Cannulation | Coronary Surgery With Cardiopulmonary Bypass | Coronary Surgery | Arterial Cannulation | Venous CannulationItaly
Clinical Trials on Restricted fluid therapy group
-
Washington University School of MedicineCompletedSurgery | Hyponatremia | Pituitary | Pituitary Tumor | HyponatremicUnited States
-
Hitit UniversityCompletedFluid Therapy | Transient Tachypnea of the NewbornTurkey (Türkiye)
-
Hutchinson Technology IncCompletedColorectal SurgeryUnited States
-
University of California, IrvineCompletedPostoperative ComplicationUnited States
-
First Affiliated Hospital of Wannan Medical CollegeCompletedTime-restricted Enteral Nutrition Versus Continuous Enteral Nutrition in Patients With Severe StrokeStroke | Time Restricted FeedingChina
-
Karaman Training and Research HospitalCompletedPostoperative Nausea and VomitingTurkey
-
Bezmialem Vakif UniversityCompletedOverweight and ObesityTurkey
-
Assiut UniversityCompleted
-
Sun Yat-sen UniversityBeijing Fresenius Kabi Pharmaceutical CoCompletedRenal Function DisorderChina
-
Rajiv Gandhi Cancer Institute & Research Center...Completed